Meeting of the Chronic Fatigue Syndrome Advisory Committee, 18998-18999 [E7-7130]

Download as PDF 18998 Federal Register / Vol. 72, No. 72 / Monday, April 16, 2007 / Notices pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR Part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The application also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Additional information on all bank holding companies may be obtained from the National Information Center website at www.ffiec.gov/nic/. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than May 11, 2007. A. Federal Reserve Bank of Richmond (A. Linwood Gill, III, Vice President) 701 East Byrd Street, Richmond, Virginia 23261-4528: 1. Cooperative Bankshares, Inc., Wilmington, North Carolina; to acquire 100 percent of the voting shares of Bank of Jefferson, Jefferson, South Carolina. Board of Governors of the Federal Reserve System, April 11, 2007. Jennifer J. Johnson, Secretary of the Board. [FR Doc. E7–7123 Filed 4–13–07; 8:45 am] BILLING CODE 6210–01–S FEDERAL RESERVE SYSTEM cprice-sewell on PROD1PC66 with NOTICES Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR Part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or VerDate Aug<31>2005 15:24 Apr 13, 2007 Jkt 211001 the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The application also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Additional information on all bank holding companies may be obtained from the National Information Center website at www.ffiec.gov/nic/. Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than May 11, 2007. A. Federal Reserve Bank of Boston (Richard Walker, Community Affairs Officer) P.O. Box 55882, Boston, Massachusetts 02106-2204: 1. BankFive, MHC, and BankFive Corporation, both of Fall River, Massachusetts; to acquire 100 percent of the voting shares, and thereby merge with New Bedford Community Bancorp and acquire Luzo Community Bank, both of New Bedford, Massachusetts. B. Federal Reserve Bank of Chicago (Burl Thornton, Assistant Vice President) 230 South LaSalle Street, Chicago, Illinois 60690-1414: 1. GC Bancorp, Inc., Chicago, Illinois; to become a bank holding company by acquiring 100 percent of the voting shares of Gold Coast Bank, Chicago, Illinois. In connection with this application Applicant also has applied to engage de novo in extending credit and servicing loans, pursuant to section 225.28 (b)(1) of Regulation Y. Board of Governors of the Federal Reserve System, April 11, 2007. Jennifer J. Johnson, Secretary of the Board. [FR Doc. E7–7124 Filed 4–13–07; 8:45 am] BILLING CODE 6210–01–S PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the Chronic Fatigue Syndrome Advisory Committee Department of Health and Human Services, Office of the Secretary, Office of Public Health and Science. ACTION: Notice. AGENCY: SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S. Department of Health and Human Services is hereby giving notice that the Chronic Fatigue Syndrome Advisory Committee (CFSAC) will hold a meeting. The meeting will be open to the public. DATES: The meeting will be held on Wednesday, May 16, 2007 and Thursday, May 17, 2007. The meeting will be held from 9 a.m. to approximately 5 p.m. on both days. ADDRESSES: Department of Health and Human Services, Hubert H. Humphrey Building, Room 800, 200 Independence Avenue, SW., Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: Dr. Anand K. Parekh, Executive Secretary, Chronic Fatigue Syndrome Advisory Committee, Department of Health and Human Services, 200 Independence Avenue, SW., Room 727H, Washington, DC 20201, or Ms. Olga Nelson at (202) 401–7899. SUPPLEMENTARY INFORMATION: CFSAC was established on September 5, 2002. The Committee was established to advise, consult with, and make recommendations to the Secretary, through the Assistant Secretary for Health, on a broad range of topics including (1) the current state of knowledge and research about the epidemiology and risk factors relating to chronic fatigue syndrome, and identifying potential opportunities in these areas; (2) current and proposed diagnosis and treatment methods for chronic fatigue syndrome; and (3) development and implementation of programs to inform the public, health care professionals, and the biomedical, academic, and research communities about chronic fatigue syndrome advances. The agenda for this meeting is being developed. The agenda will be posted on the CFSAC Web site, https:// www.hhs.gov/advcomcfs, when it is finalized. Public attendance at the meeting is limited to space available. Individuals must provide a photo ID for entry into the building where the meeting is scheduled to be held. Individuals who plan to attend and need special E:\FR\FM\16APN1.SGM 16APN1 Federal Register / Vol. 72, No. 72 / Monday, April 16, 2007 / Notices assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact person. Members of the public will have the opportunity to provide comments at the meeting. Individuals who wish to address the Committee during the public comment session must pre-register by May 11, 2007. Any individual who wishes to participate in the public comment session should call the telephone number listed in the contact information to register. Public comments will be limited to five minutes per speaker. Members of the public who wish to have printed material distributed to CFSAC members for discussion should submit, at a minimum, one copy of the material to the Executive Secretary, CFSAC, prior to close of business on May 11, 2007. Contact information for the Executive Secretary, CFSAC, is listed above. Dated: April 10, 2007. Anand K. Parekh, Executive Secretary, Chronic Fatigue Syndrome Advisory Committee. [FR Doc. E7–7130 Filed 4–13–07; 8:45 am] BILLING CODE 4150–42–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Toxicology Program (NTP); Report on Carcinogens Review Process for the 12th Report on Carcinogens (RoC) National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH), Department of Health and Human Services. AGENCY: ACTION: Notice. SUMMARY: The NTP announces its scientific review process to review nominations for the 12th RoC. The process is available on the NTP Web site https://ntp.niehs.nih.gov (select ‘‘Report on Carcinogens’’) or by contacting Dr. C.W. Jameson at the address provided below. All correspondence should be directed to Dr. C.W. Jameson, National Toxicology Program, Report on Carcinogens, 79 Alexander Drive, Building 4401, Room 3118, P.O. Box 12233, Research Triangle Park, NC 27709; telephone: (919) 541–4096, fax: (919) 541–0144, e-mail: jameson@niehs.nih.gov. cprice-sewell on PROD1PC66 with NOTICES ADDRESSES: SUPPLEMENTARY INFORMATION: VerDate Aug<31>2005 15:24 Apr 13, 2007 Jkt 211001 Background On August 17, 2006, the NTP released its draft review process applicable for nominations to the 12th RoC (71 FR 47507) and invited public comment. The NTP considered all comments received and now announces the final RoC review process for the 12th RoC. Two important elements in the RoC review process are (1) the public peer review of draft background documents by ad hoc scientific expert panels and (2) the public peer review of draft substance profiles by the NTP Board of Scientific Counselors. In addition, the NTP will also, on a trial basis, prepare a response to public comments for the 12th RoC. The RoC review process is described in more detail on the NTP Web site (https://ntp.niehs.nih.gov/ select ‘‘Report on Carcinogens’’). Background Information on the Report on Carcinogens The RoC is a congressionally mandated document (Section 301(b)(4) of the Public Health Services Act, 42 U.S.C. 241(b)(4)), published by the Secretary of Health and Human Services (HHS), that identifies agents, substances, mixtures, or exposure circumstances (collectively referred to as ‘‘substances’’) that may pose a carcinogenic hazard to human health. The Secretary, HHS, has delegated responsibility for preparing the draft report to the NTP. Substances are listed in the RoC as either known to be a human carcinogen or reasonably anticipated to be a human carcinogen. Review of nominations involves a multistep scientific review process with opportunity for public comment. At the end of this process, NTP forwards a draft RoC to the Secretary for review, approval, and transmittal to Congress and the public. The NTP solicits and encourages the broadest participation from interested individuals or parties in nominating substances for review for future RoCs. Nominations should contain a rationale for review. Appropriate background information and relevant data [e.g., journal articles, NTP Technical Reports, International Agency for Research on Cancer (IARC) listings, exposure surveys, release inventories, etc.] that support the review of a nomination should be provided or referenced when possible. Contact information for the nominator should also be included [name, affiliation (if any), address, telephone, fax, and e-mail]. PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 18999 Dated: March 19, 2007. David A. Schwartz, Director, National Institute of Environmental Health Science and National Toxicology Program. [FR Doc. E7–7111 Filed 4–13–07; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Office for Civil Rights; Delegations of Authority Notice is hereby given that I have delegated to the Director of the Office for Civil Rights the following authority vested in the Secretary of Health and Human Services. A. Subpoenas for the Health Insurance Portability and Accountability Act of 1996: Authority under Section 205(d) of the Social Security Act (42 U.S.C. 405(d)), with authority to redelegate, to issue subpoenas requiring the attendance and testimony of witnesses and the production of any evidence that relates to any matter under investigation or compliance review for failure to comply with the Health Insurance Portability and Accountability Act of 1996 (HIPAA) standards and requirements related to the privacy of individually identifiable health information at 45 CFR parts 160 and 164. Section 1176(a)(2) of the Social Security Act, 42 U.S.C. 1320d–5(a)(2), which provides authority for the imposition of civil money penalties (CMPs) for violations, makes section 1128A of the Social Security Act, 42 U.S.C. 1320a–7a, applicable to the imposition of CMPs for violations of the HIPAA administrative simplification standards. Section 1128A(j)(1), 42 U.S.C. 1320a–7a(j)(1), makes section 205(d) and (e) of the Social Security Act, 42 U.S.C. 405(d) and (e), applicable to section 1128A as the subsections are with respect to Title II of the Social Security Act. Section 205(d) and (e) authorizes the issuance of subpoenas requiring the attendance and testimony of witnesses and the production of any evidence that relates to any matter under investigation by the Secretary and the enforcement of such a subpoena in court in event of refusal to comply. B. Subpoenas for the Patient Safety and Quality Improvement Act of 2005: Authority under Section 205(d) of the Social Security Act (42 U.S.C. 405(d)), with authority to redelegate, to issue subpoenas requiring the attendance and testimony of witnesses and the production of any evidence that relates E:\FR\FM\16APN1.SGM 16APN1

Agencies

[Federal Register Volume 72, Number 72 (Monday, April 16, 2007)]
[Notices]
[Pages 18998-18999]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-7130]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Chronic Fatigue Syndrome Advisory Committee

AGENCY: Department of Health and Human Services, Office of the 
Secretary, Office of Public Health and Science.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S. 
Department of Health and Human Services is hereby giving notice that 
the Chronic Fatigue Syndrome Advisory Committee (CFSAC) will hold a 
meeting. The meeting will be open to the public.

DATES: The meeting will be held on Wednesday, May 16, 2007 and 
Thursday, May 17, 2007. The meeting will be held from 9 a.m. to 
approximately 5 p.m. on both days.

ADDRESSES: Department of Health and Human Services, Hubert H. Humphrey 
Building, Room 800, 200 Independence Avenue, SW., Washington, DC 20201.

FOR FURTHER INFORMATION CONTACT: Dr. Anand K. Parekh, Executive 
Secretary, Chronic Fatigue Syndrome Advisory Committee, Department of 
Health and Human Services, 200 Independence Avenue, SW., Room 727H, 
Washington, DC 20201, or Ms. Olga Nelson at (202) 401-7899.

SUPPLEMENTARY INFORMATION: CFSAC was established on September 5, 2002. 
The Committee was established to advise, consult with, and make 
recommendations to the Secretary, through the Assistant Secretary for 
Health, on a broad range of topics including (1) the current state of 
knowledge and research about the epidemiology and risk factors relating 
to chronic fatigue syndrome, and identifying potential opportunities in 
these areas; (2) current and proposed diagnosis and treatment methods 
for chronic fatigue syndrome; and (3) development and implementation of 
programs to inform the public, health care professionals, and the 
biomedical, academic, and research communities about chronic fatigue 
syndrome advances.
    The agenda for this meeting is being developed. The agenda will be 
posted on the CFSAC Web site, https://www.hhs.gov/advcomcfs, when it is 
finalized.
    Public attendance at the meeting is limited to space available. 
Individuals must provide a photo ID for entry into the building where 
the meeting is scheduled to be held. Individuals who plan to attend and 
need special

[[Page 18999]]

assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the designated contact person. Members of 
the public will have the opportunity to provide comments at the 
meeting. Individuals who wish to address the Committee during the 
public comment session must pre-register by May 11, 2007. Any 
individual who wishes to participate in the public comment session 
should call the telephone number listed in the contact information to 
register. Public comments will be limited to five minutes per speaker. 
Members of the public who wish to have printed material distributed to 
CFSAC members for discussion should submit, at a minimum, one copy of 
the material to the Executive Secretary, CFSAC, prior to close of 
business on May 11, 2007. Contact information for the Executive 
Secretary, CFSAC, is listed above.

    Dated: April 10, 2007.
Anand K. Parekh,
Executive Secretary, Chronic Fatigue Syndrome Advisory Committee.
 [FR Doc. E7-7130 Filed 4-13-07; 8:45 am]
BILLING CODE 4150-42-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.